Insulin-Like Growth Factor

What Insulin-Like Growth Factor Means in Everyday Medical Language

Insulin-like growth factor, often called IGF or somatomedin, is a natural hormone in the body that helps cells grow and develop. It is similar in structure to insulin, the hormone that controls blood sugar. IGF is especially important during childhood for normal growth and continues to support tissue repair and maintenance in adults. There are two main types: IGF-1 and IGF-2. IGF-1 is produced mostly by the liver when stimulated by growth hormone and helps many tissues grow and stay healthy.

Why Insulin-Like Growth Factor Can Matter in Cancer Care

Some cancer cells have many receptors for IGF on their surface, called insulin-like growth factor receptors (IGF-1R). These receptors help cancer cells grow and avoid dying. Because of this, scientists are exploring treatments that block IGF or its receptor to slow down or stop cancer growth. Medicines like MK-0646 and cixutumumab are lab-made antibodies designed to attach to the IGF-1 receptor and block its signals. These treatments are still experimental and mainly available through clinical trials. Understanding IGF and its receptor helps patients learn about new targeted therapies that focus on specific parts of cancer cells.

What Patients Might See or Hear About Insulin-Like Growth Factor

Patients may encounter the term IGF or somatomedin in medical reports, test results, or treatment discussions. It might also appear when doctors talk about experimental drugs like MK-0646 or cixutumumab that target the IGF receptor. Because IGF has several names and related proteins, it can be confusing. It’s important to ask your care team what IGF means in your specific case and how it relates to your diagnosis or treatment plan.

Where the Term Might Appear in Medical Information

Insulin-like growth factor may be mentioned in lab test results, especially when measuring growth hormone activity or diagnosing growth disorders. In cancer care, it can appear in treatment plans or clinical trial information when discussing targeted therapies that block IGF receptors. It may also show up in drug information pages about monoclonal antibodies designed to interfere with cancer cell growth.

What Insulin-Like Growth Factor Does Not Automatically Mean

Seeing IGF mentioned does not mean a cancer is caused by it or that blocking IGF will cure cancer. It also does not mean that all cancers involve IGF or that treatments targeting IGF receptors are suitable for everyone. These therapies are still being studied and are not standard treatments. The presence of IGF or its receptor is just one factor among many that doctors consider when planning care.

Common Questions Patients Can Ask Their Care Team

If you hear about insulin-like growth factor or related treatments, you might ask: What role does IGF play in my cancer? Are there tests to see if my cancer has IGF receptors? Is a treatment targeting IGF or its receptor an option for me? What are the possible benefits and risks of such treatments? How do these treatments compare to other options? Asking these questions can help you understand how IGF relates to your care.

How to Read the Term in Context

Because IGF and its receptor have several names and appear in different ways, it’s important to consider the full medical context. Don’t assume IGF alone explains your diagnosis or treatment. Instead, ask your care team to explain what IGF means in your test results, reports, or treatment plan. This helps avoid confusion and ensures you get information tailored to your situation.

Safety and Next Steps

This information is meant to help you understand insulin-like growth factor and its role in cancer care. It does not replace medical advice or decisions made by your care team. If you see IGF mentioned in your records or hear about treatments targeting IGF receptors, the best next step is to discuss with your doctors what it means for you. They can explain whether any tests or treatments involving IGF are appropriate and guide you through your options.